News

New, higher and changing tariffs will ripple through the economy and into share prices for many quarters to come.
NEW YORK (Reuters) -Woes for U.S. healthcare stocks have worsened this year driven partly by Trump administration policies, ...
Woes for U.S. healthcare stocks have worsened this year driven partly by Trump administration policies, although some ...
Yacktman Asset Management's Q2 2025 13F portfolio value dipped slightly to $7.44B. Click here to read more about the ...
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
Halozyme jumps 5.3% on second-quarter earnings and revenue beat, fueled by strong royalty growth, and a raised 2025 outlook.
Bayer AG (BAYRY) reported second-quarter 2025 core earnings of 35 cents per American Depositary Receipt (ADR), which ...
OT attended the re-launch to learn how the programme for students and newly-qualified optometrists has been refreshed to work ...
DGRO offers a high-quality, low-cost way to access dividend growth companies, making it ideal for long-term investors seeking ...